Skip to main content
Caplight Logo









Triomed AB

Triomed AB

Private
LundHealthcare & Life Scienceshttps://triomed.se/

Last Round

VC Round

Feb 24, 2016

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Triomed AB is a medical technology company that develops innovative therapeutic systems for peritoneal dialysis, including its proprietary Steady Concentration Peritoneal Dialysis (SCPD) method and the Carry Life UF platform.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

peritoneal dialysishome dialysisend-stage renal diseaseESRDsteady concentration peritoneal dialysisSCPDportable dialysismedtechultrafiltrationkidney failure treatmenttoxin removaldialysis machinerenal caremedical devicenephrology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Triomed AB Comparables

Compare Triomed AB with similar companies based on industry and business-model similarity.

Triomed AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iRen-MEDICAL
81%
Vivance
81%
Nextkidney
78%

Triomed AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 24, 2016

Key People

Founding team and executive leadership

Marcello Grondelli

Chief Executive Officer - Verkställande Direktör

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 81% MoM, reaching 1K.

  • May 15, 2026

    Monthly visitors increased 605% MoM.

Triomed AB Filings

Explore SEC and related filing metadata, where available.

Triomed AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Triomed AB's valuation, stock price, and market status.

Is Triomed AB a public or private company?

Triomed AB is a private company.

What is the current stock price of Triomed AB?

Triomed AB is a private company with no public stock price. No recent secondary market data is available.

How much is Triomed AB worth (valuation)?

Valuation information for Triomed AB is not publicly available.

Can I buy Triomed AB stock?

Triomed AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Triomed AB's last funding round?

Triomed AB's most recent funding round was VC Round on February 24, 2016.

Who are the main investors in Triomed AB?

Investor information for Triomed AB is not publicly disclosed.

Will Triomed AB IPO soon?

No public IPO plans have been announced for Triomed AB.

How can I track Triomed AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Triomed AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLund
Employee Range15
Year Founded2005
Last FundingFeb 24, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?